Bavarian Nordic A/S (OTCMKTS:BVNRY) Short Interest Up 109.8% in December

Bavarian Nordic A/S (OTCMKTS:BVNRY) saw a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 8,600 shares, a growth of 109.8% from the December 15th total of 4,100 shares. Based on an average trading volume of 27,900 shares, the short-interest ratio is presently 0.3 days.

Bavarian Nordic A/S Trading Up 2.0 %

OTCMKTS BVNRY traded up $0.18 on Thursday, hitting $8.95. 7,822 shares of the company were exchanged, compared to its average volume of 8,759. Bavarian Nordic A/S has a 12 month low of $6.86 and a 12 month high of $14.60. The company has a market cap of $2.12 billion, a PE ratio of 12.96 and a beta of 1.65. The stock has a fifty day moving average of $9.05 and a 200-day moving average of $10.10.

Bavarian Nordic A/S Company Profile

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.